DCF — ENCOMPASS HEALTH REHABILITATION HOS
Enterprise Value: $49.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$49.4M
Enterprise Value
$13.3M
PV of Cash Flows
$36.0M
PV of Terminal Value
$58.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $49.6M | $6.1M | 12.0% | $2.7M | $2.5M |
| Year 2 | $51.1M | $6.7M | 13.0% | $3.2M | $2.7M |
| Year 3 | $52.7M | $7.5M | 14.0% | $3.7M | $2.8M |
| Year 4 | $54.2M | $8.0M | 15.0% | $4.0M | $2.7M |
| Year 5 | $55.9M | $8.3M | 15.0% | $4.2M | $2.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $49.4M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$48.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.11695395799241093
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5